Ranxin Shi - Concepedia

Author

Ranxin Shi

Sanford Burnham Prebys Medical Discovery Institute

Also Known As

Ran-Xin Shi, Ranxin Shi

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Sanford Burnham Prebys Medical Discovery Institute National University of Singapore Human BioMolecular Research Institute

About

Ranxin Shi is an author at Sanford Burnham Prebys Medical Discovery Institute specializing in medicine, immunology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	216
2	Immunology	4	4	157
3	Pharmacology	4	4	194
4	Cell Biology	3	3	97
5	Biochemistry	1	1	59

Ranxin Shi

Publications

490

Citations

H-Index

Page 1

	Year	Citations
Luteolin sensitizes tumor necrosis factor-α-induced apoptosis in human tumor cells Ranxin Shi, Choon Nam Ong, Han‐Ming Shen Oncogene InflammationAnti-inflammatoryMedicineApoptosisPharmacology	2004	106
Protein Kinase C Inhibition and X-Linked Inhibitor of Apoptosis Protein Degradation Contribute to the Sensitization Effect of Luteolin on Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis in Cancer Cells Ranxin Shi, Choon Nam Ong, Han‐Ming Shen Cancer Research	2005	103
Luteolin sensitizes the anticancer effect of cisplatin via c-Jun NH2-terminal kinase–mediated p53 phosphorylation and stabilization Ranxin Shi, Qing Huang, Xinqiang Zhu, Molecular Cancer Therapeutics	2007	97
Apoptotic Activity and Mechanism of 2-Cyano-3,12-Dioxoolean-1,9-Dien-28-Oic-Acid and Related Synthetic Triterpenoids in Prostate Cancer Marc L. Hyer, Ranxin Shi, Maryla Krajewska, Cancer Research Cell Surface Dr4Chemoprevention StrategyApoptosisCell DeathCddo Analogues	2008	59
ARTS and Siah Collaborate in a Pathway for XIAP Degradation Jason B. Garrison, Ricardo G. Correa, Motti Gerlic, Molecular Cell Xiap Degradation	2010	58
PCTAIRE1-Knockdown Sensitizes Cancer Cells to TNF Family Cytokines Teruki Yanagi, Ranxin Shi, Pedro Aza‐Blanc, PLoS ONE Cancer ResearchPctaire1 Kinase ActivitySignaling PathwayMedicineReceptor Tyrosine Kinase	2015	22
Inhibition of Protein Kinase C-Driven Nuclear Factor-κB Activation: Synthesis, Structure−Activity Relationship, and Pharmacological Profiling of Pathway Specific Benzimidazole Probe Molecules Satyamaheshwar Peddibhotla, Ranxin Shi, Pasha M. Khan, Journal of Medicinal Chemistry	2010	16
Chemical Biology Strategy Reveals Pathway-Selective Inhibitor of NF-κB Activation Induced by Protein Kinase C Ranxin Shi, Daniel Ré, Eric Dudl, ACS Chemical Biology Immune RegulationImmunologyInflammationMolecular PharmacologySignaling Pathway	2010	16
Selective benzimidazole inhibitors of the antigen receptor-mediated NF-κB activation pathway Karl J. Okolotowicz, Ranxin Shi, Xueying Zheng, Bioorganic & Medicinal Chemistry Molecular PharmacologyDrug TargetMedicineImmunologyMechanism Of Action	2010	13

Page 1